Clinical Thyroidology for the Public summarizes selected research studies discussed in the previous month’s issue of Clinical Thyroidology, an official publication of the American Thyroid Association.
Editor-in-chief, Alan Farwell, MD
Volume 7 Issue 2
Now available in pdf format for saving and printing and Web page format for viewing online
PDF Format for Saving and Printing
Clinical Thyroidology for the Public Volume 7 Issue 2 (PDF file, 555 KB)
TABLE OF CONTENTS – Web Format
THYROID AND PREGNANCY How much levothyroxine should be started for hypothyroidism diagnosed during pregnancy?
Abalovich M et al Adequate levothyroxine doses for the treatment of hypothyroidism newly discovered during pregnancy. Thyroid 2013;23:1479-83. Epub September 20, 2013.
(PDF File for saving and printing, 74 KB)
HYPERTHYROIDISM Some patients with apparent Graves’ disease do not have an autoimmune thyroid disorder
Nishihara E et al, The prevalence of TSH receptor germline mutations and clinical courses in 89 hyperthyroid patients with diffuse goiter and negative anti-TSH receptor antibodies. Thyroid. November 26, 2013 [Epub ahead of print].
(PDF File for saving and printing, 77KB)
HYPERTHYROIDISM A 10-year analysis of thyrotoxic periodic paralysis
Chang C-C et al 10-year analysis of thyrotoxic periodic paralysis in 135 patients: focus on symptomatology and precipitants. Eur J Endocrinol 2013;169:529-36.
(PDF File for saving and printing, 69 KB)
THYROID CANCER When thyroglobulin is undetectable, is any further testing needed in following patients with thyroid cancer?
Giovanella L et al, Unstimulated high-sensitive thyroglobulin in follow-up of differentiated thyroid cancer patients: a meta-analysis. J Clin Endocrinol Metab. 2013 Nov 27.10.1001/jamainternmed.2013.9245.
(PDF File for saving and printing, 119 KB)
THYROID CANCER Analysis of microRNAs in papillary thyroid cancer
Dettmer M et al. Comprehensive microRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma. Thyroid 2013 Nov;23(11):1383-9.
(PDF File for saving and printing, 74 KB)
THYROID CANCER Mutations of the RAS oncogene are found in follicular variant papillary thyroid carcinoma
Gupta N et al. RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancers. J Clin Endocrinol Metab 2013;98:E914-22. Epub March 28, 2013; doi: 10.1210/jc.2012-3396.
(PDF File for saving and printing, 74 KB)
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.